Distant visual acuity in chronic psychiatric patients. A pilot study

Social Psychiatry and Psychiatric Epidemiology

Volumn 37, Issue 10, 2002, Pages 488-491

  Ungvari, Gabor S ^a   Tang, Wai Kwong ^a   Wong, Wing Kin ^a   Chiu, Helen F K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antipsychotic drugs; Chronic psychiatric illness; Deinstitutionalization; Distant visual acuity; Myopia; Rehabilitation

Indexed keywords

ALCOHOLISM; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HONG KONG; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL PATIENT; MOOD DISORDER; MYOPIA; ORGANIC PSYCHOSYNDROME; REFRACTION ERROR; SCHIZOPHRENIA; SPECTACLES; VISUAL ACUITY; VISUAL IMPAIRMENT;

CHRONIC DISEASE; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MYOPIA; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY;

EID: 0036944672     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-002-0581-4     Document Type: Article

References (18)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edn. (DSM-IV). American Psychiatric Association, Washington, DC
2. Brooks JG, Matoba AY (1992) Chlorpromazine-induced anterior segment changes. Arch Ophthalmology 110: 126
3. Brugha TS, Wing JK, Smith BL (1989) Physical health of the long-term mentally ill in the community. Is there an unmet need? Brit J Psychiatry 155: 777-781
4. Christen W, Lyinn R, Manson J, Ajani U, et al. (1996) A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276: 1147-1151
5. Elliott DB (1997) Clinical procedures in primary eye care. Butterworth Heinemann, London, pp 8-17
6. Felker B, Yazel JJ, Short D (1996) Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv 47: 1356-1363
7. Gerbaldo H, Cassady S, Maurer K, et al. (1997) The assessment of light intensity preference in psychiatric patients: a questionnaire. Acta Psychiat Scand 95: 236-241
8. Hiller R, Podgor J, Sperduto RD, et al. (1998) A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 105: 1244-1251
9. Honig A, Pop P, Tan ES, et al. (1989) Physical illness in chronic psychiatric patients from a community psychiatric unit. Brit J Psychiatry 155: 58-64
10. Lam CSY, Goh WSH, Tang YK, et al. (1994) Changes in refractive trends and optical components of Hong Kong Chinese aged over 40 years. Ophthalmic Physiol Optics 14: 383-388
11. McCarty CA, Wood CA, Fu CL, et al. (1999) Schizophrenia, psychotropic medication, and cataract. Ophthalmology 106: 683-687
12. Prien RF, DeLong SL, Cole JO, et al. (1970) Ocular changes occurring with prolonged high dose chlorpromazine therapy. Arch Gen Psychiatry 23: 464-468
13. Nouri A, Cunendet JF (1968) Les atteintes oculaires au cours de traitements prolongés aux neuroleptiques. Schweiz Med Wchschrft 98: 1708-1711
14. Oshika T (1995) Ocular adverse effects of neuropsychiatric agents. Drug Safety 12: 256-263
15. Roca RP, Breakey WR, Fischer PJ (1987) Medical care of chronic psychiatric outpatients. Hosp Comm Psychiatry 38: 741-745
16. Ruigomez A, Rodriguez LAG, Dev VJ, et al. (2000) Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 11: 620-623
17. Santhouse A, Holloway F (1999) Physical health of patients in continuing care. Advances in Psychiatric Treatment 5: 455-462
18. Smith D, Pantelis C, McGrath J, et al. (1997) Ocular abnormalities in chronic schizophrenia: clinical implications. Aust NZ J Psychiatry 31: 252-256